Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: Structure, protection and skin effects

Journal of Biomedical Nanotechnology

Volumn 3, Issue 4, 2007, Pages 317-331

  Souto, Eliana B ^a,b   Almeida, António J ^c   Müller, Rainer H ^b  

^a UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

Anisotropic diffusion; Cutaneous drug delivery; Nanostructured lipid carriers; NLC; Polymorphism; SLN; Solid lipid nanoparticles; Topical drugs

Indexed keywords

BASE; BENZYL NICOTINATE; BETAMETHASONE VALERATE; BUPIVACAINE; CHLORAMPHENICOL; CLOBETASOL PROPIONATE; CLOTRIMAZOLE; CORTISONE; CYPROTERONE ACETATE; DEXAMETHASONE; DRUG CARRIER; ESTRADIOL DERIVATIVE; HYDROCORTISONE; INDOMETACIN; KETOCONAZOLE; METRONIDAZOLE; MICONAZOLE; PILOCARPINE; PODOPHYLLOTOXIN; PREDNICARBATE; PREDNISOLONE; PROGESTERONE; SOLID LIPID NANOPARTICLE; SURFACTANT; TIMOLOL; TOBRAMYCIN; TRIPTOLIDE; UBIDECARENONE; UNINDEXED DRUG; VALDECOXIB;

ACUTE TOXICITY; CHEMICAL STRUCTURE; CHRONIC TOXICITY; COLLOID; CREAM; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG RETENTION; DRUG SOLUBILITY; DRUG STABILITY; DRUG TOLERABILITY; GELATION; HUMAN; MORPHOLOGY; NONHUMAN; PHYSICAL CHEMISTRY; PROTECTION; REVIEW; SKIN IRRITATION;

EID: 45849118730     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2007.049     Document Type: Review

References (122)

1. A. Nanda, S. Nanda, and N. M. Ghilzai, Current developments using emerging transdermal technologies in physical enhancement method. Curr. Drug Deliv. 3, 233 (2006).
2. B. C. Finnin and T. M. Morgan, Transdermal penetration enhancers: Applications, limitations, and potential. J. Pharm. Sci. 88 955 (1999).
3. S. S. Valiveti, K. S. Paudel, D. C. Hammell, M. O. Hamad, J. Chen, P. A. Crooks, and A. L. Stinchcomb, In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs. Pharm. Res. 22 981 (2005).
4. Y. Song, C. Xiao, R. Mendelsohn, T. Zheng, L. Strekowski, and B. Michniak, Investigation of iminosulfuranes as novel transdermal penetration enhancers: Enhancement activity and cytotoxicity. Pharm. Res. 22, 1918 (2005).
5. A. K. Bansal, R. K. Khar, R. Dubey, and A. K. Sharma, Alkyl ester prodrugs for improved topical delivery of ibuprofen. Indian. J. Exp. Biol. 39, 280 (2001).
6. B. Luppi, T. Cerchiara, F Bigucci, R. Basile, and V. Zecchi, Polymeric nanoparticles composed of fatty acids and polyvinylalcohol for topical application of sunscreens. J. Pharm. Pharmacol. 56, 407 (2004).
7. R. Alvarez-Roman, A. Naik, Y. N. Kalia, R. H. Guy, and H. Fessi, Enhancement of topical delivery from biodegradable nanoparticles. Pharm. Res. 21, 1818 (2004).
8. R. Schubert, Liposomes in topical application and their mode of action in the skin. Arch. Pharm. 324, 627 (1991).
9. M. J. F. Contreras, M. M. J. Soriano, and A. R. Dieguez, In vitro percutaneous absorption of all-trans retinoic acid applied in free form or encapsulated in stratum corneum lipid liposomes. Int. J. Pharm. 297, 134 (2005).
10. G. Cevc and G. Blume, New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultrade-formable drug carriers, Transfersomes. Biochim. Biophys. Acta 1514, 191 (2001).
11. A. Teichmann, U. Jacobi, H. J. Weigmann, W. Sterry, and J. Lademann, Reservoir function of the stratum corneum: Development of an in vivo method to quantitatively determine the stratum corneum reservoir for topically applied substances. Skin Pharmacol. Physiol. 18, 75 (2005).
12. M. Changez, M. Varshney, J. Chander, and A. K. Dinda, Effect of the composition of lecithin/n-propanol/isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: In vitro. Colloids Surf. B Biointerfaces 50, 18 (2006).
13. H. Wu, C. Ramachandran, N. D. Weiner, and B. J. Roessler, Topical transport of hydrophilic compounds using water-in-oil nanoemulsions. Int. J. Pharm. 220, 63 (2001).
14. C. Laugel, P. Rafidison, G. Potard, L. Aguadisch, and A. Baillet, Modulated release of triterpenic compounds from a O/W/O multiple emulsion formulated with dimethicones: Infrared spectrophotometric and differential calorimetric approaches. J. Control. Release 63, 7 (2000).
15. M. Gallarate, M. E. Carlotti, M. Trotta, and S. Bovo, On the stability of ascorbic acid in emulsified systems for topical and cosmetic use. Int. J. Pharm. 188, 233 (1999).
16. L. Olivieri, M. Seiller, L. Bromberg, E. Ron, P. Couvreur, and J. L. Grossiord, Study of the breakup under shear of a new thermally reversible water-in-oil-in-water (W/O/W) multiple emulsion. Pharm. Res. 18, 689 (2001).
17. M. Kreilgaard, Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev. 54, Suppl 1, S77 (2002).
18. E. S. Park, Y. Cui, B. J. Yun, I. J. Ko, and S. C. Chi, Transdermal delivery of piroxicam using microemulsions. Arch. Pharm. Res. 28, 243 (2005).
19. R. H. Müller, W. Mehnert, and E. B. Souto, Percutaneous Absorption, edited by R. L. Bronaugh and H. I. Maibach, Marcel Dekker, Inc., New York, Basel, Hong Kong (2005), pp. 719-738.
20. R. H. Muller, M. Radtke, and S. A. Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Deliv. Rev. 54, Suppl 1, S131 (2002).
21. E. B. Souto and R. H. Müller, Nanoparticles for Pharmaceutical Applications, edited by A. J. Domb, Y. Tabata, M. N. V. R. Kumar, and S. Farber, American Scientific Publishers, Los Angeles (2007), pp. 103-122.
22. S. Wissing, A. Lippacher, and R. H. Muller, Investigations on the occlusive properties of solid lipid nanoparticles (SLN). J. Cosmet. Sci. 52, 313 (2001).
23. S. Wissing and R. H. Muller, The influence of the crystallinity of lipid nanoparticles on their occlusive properties. Int. J. Pharm. 242, 377 (2002).
24. L. Montenegro, D. Paolino, and G. Puglisi, Effects of silicone emulsifiers on in vitro skin permeation of sunscreens from cosmetic emulsions. J. Cosmet. Sci. 55, 509 (2004).
25. E. B. Souto, A. J. Almeida, and R. H. Müller, Feasibility studies of lipid-based carriers for dermal applications. 14th International Workshop on Bioencapsulation & COST 865 Meeting, Lausanne, Switzerland, October (2006), p. 27.
26. T. de Vringer, Topical preparation containing a suspension of solid lipid particles, E.P.N. 91200664 (1992).
27. R. H. Müller and A. Dingler, A new dimension in cosmetic products by nanostructured lipid carriers (NLC) technology. Eurocosmetics 15, 38 (2007).
28. K. Westesen, H. Bunjes, and M. H. J. Koch, Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Release 48, 223 (1997).
29. G. Worle, B. Siekmann, and H. Bunjes, Effect of drug loading on the transformation of vesicular into cubic nanoparticles during heat treatment of aqueous monoolein/poloxamer dispersions. Eur. J. Pharm. Biopharm. 63, 128 (2006).
30. R. Sivaramakrishnan, C. Nakamura, W. Mehnert, H. C. Korting, K. D. Kramer, and M. Schafer-Korting, Glucocorticoid entrapment into lipid carriers - characterisation by parelectric spectroscopy and influence on dermal uptake. J. Control. Release 97, 493 (2004).
31. M. Krzic, M. Sentjurc, and J. Kristl, Improved skin oxygenation after benzyl nicotinate application in different carriers as measured by EPR oximetry in vivo. J. Control. Release 70, 203 (2001).
32. D. B. Masters and A. J. Domb, Liposphere local anesthetic timed-release for perineural site application. Pharm. Res. 15, 1038 (1998).
33. M. Kalariya, B. K. Padhi, M. Chougule, and A. Misra, Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: Formulation and clinical implications. Indian J. Exp. Biol. 43, 233 (2005).
34. F. Q. Hu, S. P. Jiang, Y. D. Du, H. Yuan, Y. Q. Ye, and S. Zeng, Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm. 314, 83 (2006).
35. F. Q. Hu, H. Yuan, H. H. Zhang, and M. Fang, Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int. J. Pharm. 239, 121 (2002).
36. E. B. Souto, SLN and NLC for Topical Delivery of Antifungals, Ph.D. Thesis, Institute of Pharmacy, Free University of Berlin, Germany ( 2005).
37. E. B. Souto, S. A. Wissing, C. M. Barbosa, and R. H. Muller, Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 278, 71 (2004).
38. E. B. Souto and R. H. Müller, Rheological and in vitro release behaviour of clotrimazole-containing aqueous SLN dispersions and commercial creams. Pharmazie 62, 505 (2007).
39. E. B. Souto, W. Mehnert, and R. H. Muller, Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. J. Microencapsul. 23, 417 (2006).
40. J. Stecová, W. Mehnert, T. Blaschke, B. Kleuser, R. Sivaramakrishnan, C. C. Zouboulis, H. Seltmann, H. C. Korting, K. D. Kramer, and M. Schäfer-Korting, Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: Particle characterisation and skin uptake. Pharm. Res. 24, 991 (2007).
41. M. R. Gasco, S. Morel, and R. Carpignano, Optimization of the incorporation of desoxycortisone acetate in lipospheres. Eur. J. Pharm. Biopharm. 38, 7 (1992).
42. M. Fresta, C. Bucolo, A. Maltese, S. Mangiafico, and G. Puglisi, Pegylated solid lipid nanospheres as ophthalmic delivery systems of dexamethasone. Proceedings of the 4th World Meeting APGI/APV, Florence, Italy (2002), pp. 941-942.
43. J. Seki, S. Sonoke, A. Saheki, H. Fukui, H. Sasaki, and T. Mayumi, A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting. Int. J. Pharm. 273, 75 ( 2004).
44. I. Friedrich and C. C. Muller-Goymann, Characterization of solidified reverse micellar solutions (SRMS) and production development of SRMS-based nanosuspensions. Eur. J. Pharm. Biopharm. 56, 111 ( 2003).
45. T. Eldem, P. Speiser, and A. Hinkal, Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm. Res. 8, 47 ( 1991).
46. R. Bodmeier, J. Wang, and H. Bhagwatwar, Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs. J. Microencapsul. 9, 89 (1992).
47. R. Cavalli, E. Peira, O. Caputo, and M. R. Gasco, Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with beta-cyclodextrins. Int. J. Pharm. 182, 59 (1999).
48. M. Ricci, C. Puglia, F. Bonina, C. Di Giovanni, S. Giovagnoli, and C. Rossi, Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): In vitro and in vivo studies. J. Pharm. Sci. 94, 1149 (2005).
49. E. B. Souto and R. H. Muller, SLN and NLC for topical delivery of ketoconazole. J. Microencapsul. 22, 501 (2005).
50. M. Ozyazici, E. H. Gokce, and G. Ertan, Release and diffusional modeling of metronidazole lipid matrices. Eur. J. Pharm. Biopharm. 63, 331 (2006).
51. J. Kuntsche, K. Westesen, M. Drechsler, M. H. Koch, and H. Bunjes, Supercooled smectic nanoparticles: A potential novel carrier system for poorly water soluble drugs. Pharm. Res. 21, 1834 (2004).
52. R. Cavalli, S. Morel, M. R. Gasco, P. Chetoni, and M. F. Saettone, Preparation and evaluation in vitro of colloidal lipospheres containing pilocarpine as ion pair. Int. J. Pharm. 117, 243 ( 1995).
53. H. Chen, X. Chang, D. Du, W. Liu, J. Liu, T. Weng, Y. Yang, H. Xu, and X. Yang, Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J. Control. Release 110, 296 (2006).
54. C. S. Maia, W. Mehnert, M. Schaller, H. C. Korting, A. Gysler, A. Haberland, and M. Schafer-Korting, Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target 10, 489 (2002).
55. C. S. Maia, W. Mehnert, and M. Schafer-Korting, Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm. 196, 165 (2000).
56. A. zur Muhlen, C. Schwarz, and W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism. Eur. J. Pharm. Biopharm. 45, 149 (1998).
57. A. zur Muhlen and W. Melinert, Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie 53, 552 (1998).
58. R. Cortesi, E. Esposito, G. Luca, and C. Nastruzzi, Production of lipospheres as carriers for bioactive compounds. Biomaterials 23, 2283 (2002).
59. R. Cavalli, M. R. Gasco, and S. Morel, Behaviour of timolol incorporated in lipospheres in the presence of series of phosphate esters. STP Pharma. Sci. 2, 514 (1992).
60. R. Cavalli, M. R. Gasco, P. Chetoni, S. Burgalassi, and M. F. Saettone, Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int. J. Pharm. 238, 241 (2002).
61. Z. Mei, H. Chen, T. Weng, Y. Yang, and X. Yang, Solid lipid nanoparticle and microemulsion for topical delivery of triptolide. Eur. J. Pharm. Biopharm. 56, 189 (2003).
62. Z. Mei, Q. Wu, S. Hu, X. Li, and X. Yang, Triptolide loaded solid lipid nanoparticle hydrogel for topical application. Drug Dev. Ind. Pharm. 31, 161 (2005).
63. Z. Mei, X. Li, Q. Wu, S. Hu, and X. Yang, The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle. Pharmacol. Res. 51, 345 (2005).
64. F. L. Xiong, H. B. Chen, X. L. Chang, Y. J. Yang, H. B. Xu, and X. L. Yang, Research progress of triptolide-loaded nanoparticles delivery systems. Conf. Proc. IEEE Eng. Med. Biol. Soc. 5, 4966 (2005).
65. H. Bunjes, M. Drechsler, M. H. Koch, and K. Westesen, Incorporation of the model drug ubidecarenone into solid lipid nanoparticles. Pharm. Res. 18, 287 (2001).
66. S. A. Wissing, R. H. Muller, L. Manthei, and C. Mayer, Structural characterization of Q10-Ioaded solid lipid nanoparticles by NMR spectroscopy. Pharm. Res. 21, 400 (2004).
67. V. Teeranachaideekul, E. B. Souto, V. B. Junyaprasert, and R. H. Muller, Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - Development, physicochemical characterization and in vitro release studies. Eur. J. Pharm. Biopharm. 67, 141 (2007).
68. M. Joshi and V. Patravale, Formulation and evaluation of Nano-structured Lipid Carrier (NLC)-based gel of Valdecoxib. Drug Dev. Ind. Pharm. 32, 911 (2006).
69. P. Speiser, Lipidnanopellets als Trägersystem für Arzneimittel zur peroralen Anwendung. European Patent EP 0167825 (1990).
70. A. J. Domb, Liposheres for controlled delivery of substances. USP Patent 188837 (1993).
71. R. H. Müller and J. S. Lucks, Arzneistoffträger aus festen Lipidteilchen - Feste Lipidnanosphären (SLN). German Patent Application P4131562.6 (1991).
72. R. H. Müller and J. S. Lucks, Arzneistoffträger aus festen Lipidteilchen - Feste Lipid Nanosphären (SLN). European Patent 0605497 (1996).
73. M. R. Gasco, Method for producing solid lipid microspheres having a narrow size distribution. US Patent 5 250 236 (1993).
74. R. H. Müller, K. Mäder, A. Lippacher, and V. Jenning, Festflüssig (halbfeste) Lipidpartikel und Verfahren zur Herstellung hochkonzentrierter Lipidpartikeldispersionen, in PCT application PCT/ EP00/04565 (1998).
75. E. B. Souto and R. H. Müller, Nanoparticulate Drug Delivery Systems: Recent Trends and Emerging Technologies, edited by D. Thassu, M. Deleers, and Y. Pathak, Informa Healthcare, CRC Press, New York (2007), pp. 213-233.
76. R. Cavalli, O. Caputo, E. Marengo, F. Pattarino, and M. R. Gasco, The effect of the components of microemulsions on both size and crystalline structure of solid lipid nanoparticles (SLN) containing a series of model molecules. Pharmazie 53, 392 (1998).
77. R. Cavalli, E. Marengo, L. Rodriguez, and M. R. Gasco, Effects of some experimental factors on the production process of solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 43, 110 (1996).
78. B. Heurtault, P. Saulnier, B. Pech, J. E. Proust, and J. P. Benoit, A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19, 875 (2002).
79. B. Heurtault, P. Saulnier, B. Pech, J. E. Proust, J. Richard, and J. P. Benoit, Nanocapsules lipidiques, procédé de préparation et utilisation comme médicament, French Patent: W0 01/64328 A1 (2000).
80. B. Heurtault, P. Saulnier, B. Pech, M. C. Venier-Julienne, J. E. Proust, R. Phan-Tan-Luu, and J. P. Benoit, The influence of lipid nanocapsule composition on their size distribution. Eur. J. Pharm. Sci. 18, 55 (2003).
81. C. Charcosset, A. El-Harati, and H. Fessi, Preparation of solid lipid nanoparticles using a membrane contactor. J. Control. Release 108, 112 (2005).
82. C. Charcosset and H. Fessi, A new process for drug loaded nanocapsules preparation using a membrane contactor. Drug Dev. Ind. Pharm. 31, 987 (2005).
83. B. Sjöström and B. Bergenståhl, Preparation of submicron drug particles in lecithin-stabilized o/w emulsions. I. Model studies of the precipitation of cholesteryl acetate. Int. J. Pharm. 88, 53 ( 1992).
84. B. Siekmann and K. Westesen, Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions. Eur. J. Pharm. Biopharm. 43, 104 (1996).
85. H. Reithmeier, J. Herrmann, and A. Gopferich, Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int. J. Pharm. 218, 133 (2001).
86. M. García-Fuentes, D. Torres, and M. J. Alonso, Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf. B Biointerfaces 27, 159 (2002).
87. C. Fessi, J. P. Devissaguet, F. Puisieux, and C. Thies, Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent 5,118,528 (1992).
88. F. Q. Hu, S. P. Jiang, Y. Z. Du, H. Yuan, Y. Q. Ye, and S. Zeng, Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf. B Biointerfaces 45, 167 (2005).
89. F. Q. Hu, Y. Hong, and H. Yuan, Preparation and characterization of solid lipid nanoparticles containing peptide. Int. J. Pharm. 273, 29 (2004).
90. M. A. Schubert and C. C. Muller-Goymann, Solvent injection as a new approach for manufacturing lipid nanoparticles-evaluation of the method and process parameters. Eur. J. Pharm. Biopharm. 55, 125 (2003).
91. A. Dubes, H. Parrot-Lopez, W. Abdelwahed, G. Degobert, H. Fessi, P. Shahgaldian, and A. W. Coleman, Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. Eur. J. Pharm. Biopharm. 55, 279 ( 2003).
92. D. Quintanar-Guerrero, E. Allemann, H. Fessi, and E. Doelker, Pseudolatex preparation using a novel emulsion-diffusion process involving direct displacement of partially water-miscible solvents by distillation. Int. J. Pharm. 188, 155 (1999).
93. M. Trotta, F. Debernardi, and O. Caputo, Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int. J. Pharm. 257, 153 (2003).
94. P. Shahgaldian, J. Gualbert, K. Aissa, and A. W. Coleman, A study of the freeze-drying conditions of calixarene based solid lipid nanoparticles. Eur. J. Pharm. Biopharm. 55, 181 (2003).
95. R. H. Muller, K. Mader, and S. Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 50, 161 (2000).
96. G. Lukowski and U. Werner, Investigation of surface and drug release of solid lipid nanoparticles loaded with acyclovir. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. 25, 425 (1998).
97. E. B. Souto, S. A. Wissing, C. M. Barbosa, and R. H. Muller, Comparative study between the viscoelastic behaviors of different lipid nanoparticle formulations. J. Cosmet. Sci. 55, 463 (2004).
98. V. Jenning, M. Schafer-Korting, and S. Gohla, Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties. J. Control. Release 66, 115 (2000).
99. A. zur Mühlen, E. zur Mühlen, H. Niehus, and W. Mehnert, Atomic force microscopy studies of solid lipid nanoparticles. Pharm. Res. 13, 1411 (1996).
100. W. Mehnert and K. Mader, Solid lipid nanoparticles: Production, characterization and applications. Adv. Drug Deliv. Rev. 47, 165 (2001).
101. H. Bunjes, B. Siekmann, and K. Westesen, Submicron Emulsions in Drug Targeting and Delivery, edited by S. Benita, Harwood Academic Publishers, Amsterdam (1998), pp. 175-204.
102. H. Bunjes, F. Steiniger, and W. Richter, Visualizing the structure of triglyceride nanoparticles in different crystal modifications. Langmuir 23, 4005 (2007).
103. H. Bunjes, K. Westesen, and M. H. J. Koch, Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int. J. Pharm. 129, 159 (1996).
104. B. Siekmann and K. Westesen, Submicron Emulsions in Drug Targeting and Delivery, edited by S. Benita, Harwood Academic Publishers, Amsterdam (1998), pp. 205-218.
105. F. Kaneko, Crystallization Processes in Fats and Lipid Systems, edited by N. Garti and K. Sato, Marcel Dekker, Inc., New York (2001), pp. 53-97.
106. K. Westesen and B. Siekmann, Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int. J. Pharm. 151, 35 (1997).
107. C. Freitas and R. H. Müller, Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticles (SLN™) dispersions. Int. J. Pharm. 168, 221 (1998).
108. A. Lippacher, R. H. Muller, and K. Mader, Investigation on the viscoelastic properties of lipid based colloidal drug carriers. Int. J. Pharm. 196, 227 (2000).
109. E. B. Souto, A. J. Almeida, and R. H. Müller, SLN and NLC as viscoelastic enhancers for topical drug delivery. 14th International Workshop on Bioencapsulation & COST 865 Meeting, Lausanne, Switzerland, October (2006), pp. 06-5.
110. E. B. Souto, S. A. Wissing, C. M. Barbosa, and R. H. Muller, Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations. Eur. J. Pharm. Biopharm. 58, 83 ( 2004).
111. R. H. Muller and C. M. Keck, Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles. J. Biotechnol. 113, 151 (2004).
112. A. Gysler, B. Kleuser, W. Sippl, K. Lange, H. C. Korting, H. D. Holtje, and H. C. Korting, Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin. Pharm. Res. 16, 1386 (1999).
113. A. Gysler, K. Lange, H. C. Korting, and M. Schafer-Korting, Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts. Pharm. Res. 14, 793 (1997).
114. K. Lange, A. Gysler, M. Bader, B. Kleuser, H. C. Korting, and M. Schafer-Korting, Prednicarbate versus conventional topical glucocorticoids: Pharmacodynamic characterization in vitro. Pharm. Res. 14, 1744 (1997).
115. V. Jenning, A. Gysler, M. Schafer-Korting, and S. H. Gohla, Vitamin A loaded solid lipid nanoparticles for topical use: Occlusive properties and drug targeting to the upper skin. Eur. J. Pharm. Biopharm. 49, 211 (2000).
116. U. Munster, C. Nakamura, A. Haberland, K. Jores, W. Mehnert, S. Rummel, M. Schaller, H. C. Korting, C. Zouboulis Ch, U. Blume-Peytavi, and M. Schafer-Korting, RU 58841-myristate-prodrug development for topical treatment of acne and androgenetic alopecia. Pharmazie 60, 8 ( 2005).
117. G. Cevc, A. Schatzlein, and H. Richardsen, Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim. Biophys. Acta 1564, 21 (2002).
118. D. D. Verma, S. Verma, G. Blume, and A. Fahr, Particle size of liposomes influences dermal delivery of substances into skin. Int. J. Pharm. 258, 141 (2003).
119. R. H. Müller and A. Dingler, The next generation after the liposomes: Solid lipid nanoparticles (SLN™, Lipopearls™) as dermal carrier in cosmetics. Eurocosmetics 7/8, 18 (1998).
120. FDA, Citizen petition to FDA to amend its regulations for products composed of engineered nanoparticles generally and sunscreen drug products composed of engineered nanoparticles specifically Docket No. 2006P-0210 (2006).
121. A. O. Gamer, E. Leibold, and B. van Ravenzwaay, The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol. In Vitro 20, 301 (2006).
122. G. J. Nohynek, J. Lademann, C. Ribaud, and M. S. Roberts, Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit. Rev. Toxicol. 37, 251 (2007).